Recent studies support the potential therapeutic roles of IGF signaling in the prevention of, noting that administration of rhIGF1 and rhIGFBP3 decreases the severity of BPD in preliminary clinical studies in preterm infants (22). Here, IGF1 is linked to bronchopulmonary dysplasia.